Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Non-Current Assets: 2010-2025

Historic Non-Current Assets for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $1.9 billion.

  • BIO-TECHNE's Non-Current Assets fell 8.18% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year decrease of 8.18%. This contributed to the annual value of $245.7 million for FY2025, which is 2.16% down from last year.
  • Latest data reveals that BIO-TECHNE reported Non-Current Assets of $1.9 billion as of Q3 2025, which was up 680.01% from $245.7 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Non-Current Assets ranged from a high of $2.2 billion in Q3 2023 and a low of $207.9 million during Q2 2021.
  • For the 3-year period, BIO-TECHNE's Non-Current Assets averaged around $1.6 billion, with its median value being $2.0 billion (2023).
  • In the last 5 years, BIO-TECHNE's Non-Current Assets increased by 20.30% in 2023 and then declined by 8.18% in 2025.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Non-Current Assets stood at $1.7 billion in 2021, then rose by 4.88% to $1.8 billion in 2022, then climbed by 19.01% to $2.1 billion in 2023, then declined by 4.87% to $2.0 billion in 2024, then declined by 8.18% to $1.9 billion in 2025.
  • Its Non-Current Assets stands at $1.9 billion for Q3 2025, versus $245.7 million for Q2 2025 and $2.0 billion for Q1 2025.